Table 9.
Baseline | Day 1 | Day 3 | Day 7 | Day 14 | ||
---|---|---|---|---|---|---|
Nepafenac group | Mean | 0.0 | 1.3 | 0.9 | 0.5 | 0.3 |
Std | 0.0 | 0.6 | 0.7 | 0.6 | 0.6 | |
N | 106 | 105 | 105 | 105 | 105 | |
Min | 0 | 0 | 0 | 0 | 0 | |
Max | 0 | 4 | 4 | 4 | 4 | |
Placebo group | Mean | 0.0 | 1.2 | 1.0 | 1.0 | 0.9 |
Std | 0.0 | 0.5 | 0.7 | 0.9 | 0.9 | |
N | 105 | 105 | 105 | 105 | 105 | |
Min | 0 | 0 | 0 | 0 | 0 | |
Max | 0 | 2 | 4 | 4 | 4 | |
P value | N/A | 0.6905 | 0.1638 | <0.0001 | <0.0001 |
Baseline P value is from t test; non-baseline P values are LSMeans by visit; test = repeated measure ANOVA, main effect of treatment P < 0.0001; treatment by visit interaction P < 0.0001
Min minimum, Max maximum, Std standard deviation